Trend Pharma: payers demand real-world value while regulators tighten scrutiny of AI and data integrity

Summary

For pharma NTT DATA reports pipelines shifting to high-science, high-cost therapies while payers demand real-world value and regulators intensify scrutiny of AI use, data integrity and good practice compliance, on top of rising digital, data and ESG expectations.

Classification

Main topicBio & Health Tech

Secondary topicsIndustry & Supply Chains Tech Regulation & Digital Policy

Region menusGlobal

Impactscope:global

Time horizon0-3 years (2026-07-26)

Last updated2026-07-29 04:49:52

Evidence 1

Technology Foresight 2026: Sustaining growth in the era of mass intelligence NTT DATA page=84;section=Technology in context: Foresight across industries / Industry perspectives / Pharma 2026-03 accessed 2026-07-26

Observed signals 2

SignalA global pharma company simulates enrollment and diversity targets on a clinical-trial digital twin
SignalThe US Inflation Reduction Act and health technology assessment regimes are named as pricing pressure

Part of issues 0

No objects.

Relation types: supports

Public id: fm-d6da1bc86cf4